Seeking Alpha

Shares of Abbott Labs (ABT -1.9%) slide after the National Institutes of Health stops a clinical...

Shares of Abbott Labs (ABT -1.9%) slide after the National Institutes of Health stops a clinical trial early that was looking at cholesterol treatments after finding that the company's drug Niaspan doesn't reduce the risk of heart attacks and strokes. "It would be premature to extrapolate these results to a broader patient population at this time," Abbott says (PR).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|